NDC11 31722031302
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 31722-0313-02 | 31722-0313 |
| 31722-0313-2 | 31722-0313 |
| 31722-313-02 | 31722-313 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Camber Pharmaceuticals Inc. | d8b5eb77-b393-4cd7-86c5-d2a9d131f96d | 2026-04-30 | Warnings, Adverse reactions | 31722-313-02 31722-313 31722031302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.